hrcak mascot   Srce   HID

Acta Pharmaceutica, Vol. 61 No. 2, 2011.

Izvorni znanstveni članak
https://doi.org/10.2478/v10007-011-0012-8

Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting

AMIT BANSAL ; UGC-Centre for Advanced Studies, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh-160014, India
DEEPAK N. KAPOOR ; UGC-Centre for Advanced Studies, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh-160014, India
RISHI KAPIL ; UGC-Centre for Advanced Studies, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh-160014, India
NEHA CHHABRA ; Hindu College of Pharmacy, Sonepat, Haryana, India
SANJU DHAWAN ; UGC-Centre for Advanced Studies, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh-160014, India

Puni tekst: engleski, pdf (259 KB) str. 141-156 preuzimanja: 1.011* citiraj
APA 6th Edition
BANSAL, A., KAPOOR, D.N., KAPIL, R., CHHABRA, N. i DHAWAN, S. (2011). Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting. Acta Pharmaceutica, 61 (2), 141-156. https://doi.org/10.2478/v10007-011-0012-8
MLA 8th Edition
BANSAL, AMIT, et al. "Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting." Acta Pharmaceutica, vol. 61, br. 2, 2011, str. 141-156. https://doi.org/10.2478/v10007-011-0012-8. Citirano 24.06.2019.
Chicago 17th Edition
BANSAL, AMIT, DEEPAK N. KAPOOR, RISHI KAPIL, NEHA CHHABRA i SANJU DHAWAN. "Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting." Acta Pharmaceutica 61, br. 2 (2011): 141-156. https://doi.org/10.2478/v10007-011-0012-8
Harvard
BANSAL, A., et al. (2011). 'Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting', Acta Pharmaceutica, 61(2), str. 141-156. doi: https://doi.org/10.2478/v10007-011-0012-8
Vancouver
BANSAL A, KAPOOR DN, KAPIL R, CHHABRA N, DHAWAN S. Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting. Acta Pharm. [Internet]. 2011 [pristupljeno 24.06.2019.];61(2):141-156. doi: https://doi.org/10.2478/v10007-011-0012-8
IEEE
A. BANSAL, D.N. KAPOOR, R. KAPIL, N. CHHABRA i S. DHAWAN, "Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting", Acta Pharmaceutica, vol.61, br. 2, str. 141-156, 2011. [Online]. doi: https://doi.org/10.2478/v10007-011-0012-8

Sažetak
Bovine serum albumin (BSA) nanoparticles loaded with paclitaxel (PTX) were prepared using a desolvation technique. A 32 full factorial design (FFD) was employed to formulate nanoparticles. Nanoparticles were characterized for particle size by photon correlation spectroscopy and surface morphology by scanning electron microscopy (SEM) and transmission electron microscopy (TEM). Encapsulation efficiency, zeta potential and particle yield were also determined. Response surface linear modelling (RSLM) was used to predict the optimal formulation. Various models were applied to determine the release mechanism from PTX nanoparticles. The effect of drug-polymer ratio on the release profile of formulations was observed and was applied to determine the suitability of the predicted optimal formulation. A preliminary study to determine the feasibility of targeting the prepared nanoparticles to brain was also carried out using mice as in vivo models.

Ključne riječi
paclitaxel; bovine serum albumin; nanoparticles; desolvation; brain targeting; factorial design

Hrčak ID: 66183

URI
https://hrcak.srce.hr/66183

[hrvatski]

Posjeta: 1.290 *